Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients show molecular alterations in the ALK gene involved in cell multiplication.

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

Drug discovery efforts have expanded beyond the traditional approaches of small molecules and antibodies to include cells.

Professor Yu, from UQ's Australian Institute for Bioengineering and Nanotechnology (AIBN), said a new solution was needed because TNBC cancer cells ... as a potential treatment option for TNBC ...

A team of researchers from the Rice Biotech Launch Pad at Rice University has developed an implantable "cytokine factory" ...

Chemotherapy and other common forms of cancer treatment attack rapidly dividing ... Ph.D., a professor of bioengineering at the University of Pennsylvania and co-lead author of the study.

Northeastern University researchers resurrected an extinct plant gene, turning back the evolutionary clock to pave a path forward for the development and discovery of new drugs.

Recently, a Korean research team has developed a high-efficiency 'nanomaterial (MnZn-SPION-7)' that can be used ...

Since Trump took office on January 20, research funding from the National Institutes of Health has plummeted by more than $3 billion compared with the pace of funding in 2024, according to an analysis ...